866-997-4948(US-Canada Toll Free)

Global Market Study on Hepatitis C Treatment: Online Pharmacies Distribution Channel Segment Expected to Register the Fastest CAGR of 13.5% During 2016 - 2024

Published By :

Persistence Market Research

Published Date : Nov 2016

Category :

Pharmaceutical

No. of Pages : 168 Pages

In this report, Persistence Market Research (PMR) offers an eight year forecast of the global hepatitis C treatment market between 2016 and 2024. The current study reveals the market trends and market dynamics that are expected to positively affect the current market environment and future scenario of the hepatitis C treatment market over the forecast period.

This report covers the global hepatitis C treatment market performance in terms of revenue contribution. The report includes key trends, drivers, restraints, and opportunities influencing growth of the global hepatitis C treatment market. Impact analysis of key growth drivers and restraints, based on the weighted average model, are included to better equip clients with crystal clear decision-making insights.

The global hepatitis C treatment market report begins with the executive summary and definitions of various categories and their usage in various industries. It is followed by market overview of the global hepatitis C treatment market, which includes PMRs analysis of market trends, drivers, restraints and opportunities that are affecting growth of the global hepatitis C treatment market. Furthermore, to understand the popularity of the market segment and regions, the attractiveness index with elaborated insights on the same is provided, which will show the markets attractiveness based on factors such as CAGR and incremental $ opportunity.

On the basis of drug class, hepatitis C treatment market is segmented into HCV Protease Inhibitors, HCV Polymerase Inhibitors, HCV NS5A Inhibitors, Combination Therapy and Interferon & Antiviral, which is again sub-divided into various drugs sub segments. By distribution channel, hepatitis C treatment market is segmented into hospital pharmacies, retail pharmacies and online pharmacies.

In the final section of the report on global hepatitis C treatment market, the dashboard view of the companies is provided to compare the current industrial scenario and their contribution to the total hepatitis C treatment market. Moreover, it is primarily designed to provide clients with an objective and detailed comparative assessment of key providers specific to a market segment. Report audiences can gain segment-specific manufacturer insights to identify and evaluate key competitors based on an in-depth assessment of their capabilities and success in the hepatitis C treatment marketplace.

Research methodology

To ascertain the global hepatitis C treatment market size, we have taken into account the revenue generated by the various hepatitis C treatment drug manufacturers globally. The forecast presented here assesses the total revenue generated by value across the global hepatitis C treatment market. In order to provide an accurate forecast, we initiated by sizing up the current market, which forms the basis on how the hepatitis C treatment market is expected to develop in the future. Given the characteristics of the market, we triangulated the outcome on the basis of three different types of analysis; based on supply side, downstream industry demand and the economic envelope.

In addition, it is imperative to note that in an ever-fluctuating global economy, we not only conduct forecasts in terms of CAGR, but also analyze the market based on key parameters, such as year-on-year (Y-o-Y) growth rates, to understand the predictability of the global hepatitis C treatment market and identify the right opportunities across the market.

The hepatitis C treatment market has been analyzed in terms of basis point share (BPS) to understand the individual segments relative contributions to market growth. This detailed level of information is important for identifying various key trends in the global hepatitis C treatment market.

Another key feature of this report is the analysis of key segments in terms of absolute dollar opportunity. This is overlooked while forecasting the market. However, absolute dollar opportunity is critical for evaluating the scope of opportunity that a provider can look to achieve, as well as to identify potential resources from a delivery perspective of the global hepatitis C treatment market. The overall absolute dollar opportunity along with the segmental split is mentioned in the report. To understand key growth segments in terms of growth and adoption for hepatitis C treatment globally, PMR has developed the hepatitis C treatment market attractiveness index to help providers identify real market opportunities.

Company Profiles

  •     Gilead Sciences, Inc.
  •      AbbVie Inc.
  •      Kadmon Holdings, Inc.
  •      F. Hoffmann-La Roche Ltd
  •      GlaxoSmithKline plc.
  •      Bristol-Myers Squibb Company
  •      Merck & Co., Inc.
  •      Johnson & Johnson
  •      Others.

Table of Content

1. Executive Summary

2. Assumptions and Acronyms

3. Research Methodology

4. Hepatitis C Treatment Market Overview

4.1. Introduction
4.1.1. Hepatitis C Treatment Market Definition
4.1.2. Hepatitis C Treatment Market Current treatment options
4.1.3. Hepatitis C Treatment Market Taxonomy
4.1.4. Hepatitis C Treatment Market Parent Market Overview
4.2. Hepatitis C Treatment Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunity
4.3. Pipeline Analysis
4.4. Disease Epidemiology, By Region

5. Global Hepatitis C Treatment Market Analysis Scenario
5.1. Market Value (US$ Mn) Forecast
5.1.1. Y-o-Y Growth Projections
5.1.2. Absolute $ Opportunity
5.2. Hepatitis C Treatment Market Trends
5.3. Regional Average Pricing Analysis (2015)
5.4. Global Hepatitis C Treatment Market Snapshot (2015)
5.4.1. Market Share, By Region
5.4.2. Market Share, By Drug Class
5.4.3. Market Share, By Distribution Channel

6. Global Hepatitis C Treatment Market Analysis, By Drug Class
6.1. Introduction
6.1.1. Y-o-Y Growth Comparison, By Drug Class
6.1.2. Market Share & Basis Point (BPS) Analysis, By Drug Class
6.2. Market Forecast, By Drug Class
6.2.1. HCV Protease Inhibitors
6.2.1.1. Absolute $ Opportunity
6.2.1.2. Market Value (US$ Mn) Forecast
6.2.2. HCV Polymerase Inhibitors
6.2.2.1. Absolute $ Opportunity
6.2.2.2. Market Value (US$ Mn) Forecast
6.2.3. HCV NS5A Inhibitors
6.2.3.1. Absolute $ Opportunity
6.2.3.2. Market Value (US$ Mn) Forecast
6.2.4. Combination Therapy
6.2.4.1. Absolute $ Opportunity
6.2.4.2. Market Value (US$ Mn) Forecast
6.2.4.3. Ledipasvir & Sofosbuvir
6.2.4.4. Ombitasvir, Paritaprevir, Ritonavir & Dasabuvir
6.2.4.5. Elbasvir & Grazoprevir
6.2.4.6. Others
6.2.5. Interferon and Antiviral
6.2.5.1. Absolute $ Opportunity
6.2.5.2. Market Value (US$ Mn) Forecast
6.2.5.3. Peginterferon alfa-2a
6.2.5.4. Peginterferon alfa-2b
6.2.5.5. Ribavirin
6.2.5.6. Others
6.3. Market Attractiveness Analysis, By Drug Class
6.4. Prominent Trends

7. Global Hepatitis C Treatment Market Analysis, By Distribution Channel
7.1. Introduction
7.1.1. Y-o-Y Growth Comparison, By Distribution Channel
7.1.2. Market Share & Basis Point (BPS) Analysis, By Distribution Channel
7.2. Market Forecast, By Distribution Channel
7.2.1. Hospital Pharmacies
7.2.1.1. Absolute $ Opportunity
7.2.1.2. Market Value (US$ Mn) Forecast
7.2.2. Retail Pharmacies
7.2.2.1. Absolute $ Opportunity
7.2.2.2. Market Value (US$ Mn) Forecast
7.2.3. Online Pharmacies
7.2.3.1. Absolute $ Opportunity
7.2.3.2. Market Value (US$ Mn) Forecast

8. Global Hepatitis C Treatment Market Analysis, By Region
8.1. Introduction
8.1.1. Y-o-Y Growth Projections, By Region
8.1.2. Market Share & Basis Point (BPS) Analysis, By Region
8.2. Market Forecast, By Region
8.2.1. North America Market Value (US$ Mn) Forecast
8.2.2. Latin America Market Value (US$ Mn) Forecast
8.2.3. Europe Market Value (US$ Mn) Forecast
8.2.4. APAC Market Value (US$ Mn) Forecast
8.2.5. MEA Market Value (US$ Mn) Forecast
8.3. Regional Attractiveness Analysis

9. North America Hepatitis C Treatment Market Analysis
9.1. Introduction
9.1.1. Y-o-Y Growth Projections, By Country
9.1.2. Market Share & Basis Point (BPS) Analysis, By Country
9.2. Key Regulations
9.3. Key Trends
9.4. North America Market Forecast
9.4.1. Market Value (US$ Mn) Forecast, By Country
9.4.1.1. U.S. Absolute $ Opportunity
9.4.1.2. Canada Absolute $ Opportunity
9.4.2. Market Value (US$ Mn) Forecast, By Drug Class
9.4.3. Market Value (US$ Mn) Forecast, By Distribution Channel
9.5. Market Attractiveness Analysis
9.5.1. By Country
9.5.2. By Drug Class
9.5.3. By Distribution Channel

10. Latin America Hepatitis C Treatment Market Analysis
10.1. Introduction
10.1.1. Y-o-Y Growth Projections, By Country
10.1.2. Market Share & Basis Point (BPS) Analysis, By Country
10.2. Key Regulations
10.3. Key Trends
10.4. Latin America Market Forecast
10.4.1. Market Value (US$ Mn) Forecast, By Country
10.4.1.1. Brazil Absolute $ Opportunity
10.4.1.2. Mexico Absolute $ Opportunity
10.4.1.3. Rest of Latin America Absolute $ Opportunity
10.4.2. Market Value (US$ Mn) Forecast, By Drug Class
10.4.3. Market Value (US$ Mn) Forecast, By Distribution Channel
10.5. Market Attractiveness Analysis
10.5.1. By Country
10.5.2. By Drug Class
10.5.3. By Distribution Channel

11. Europe Hepatitis C Treatment Market Analysis
11.1. Introduction
11.1.1. Y-o-Y Growth Projections, By Country
11.1.2. Market Share & Basis Point (BPS) Analysis, By Country
11.2. Key Regulations
11.3. Key Trends
11.4. Europe Market Forecast
11.4.1. Market Value (US$ Mn) Forecast, By Country
11.4.1.1. U.K. Absolute $ Opportunity
11.4.1.2. France Absolute $ Opportunity
11.4.1.3. Germany Absolute $ Opportunity
11.4.1.4. Rest of Europe Absolute $ Opportunity
11.4.2. Market Value (US$ Mn) Forecast, By Drug Class
11.4.3. Market Value (US$ Mn) Forecast, By Distribution Channel
11.5. Market Attractiveness Analysis
11.5.1. By Country
11.5.2. By Drug Class
11.5.3. By Distribution Channel

12. APAC Hepatitis C Treatment Market Analysis
12.1. Introduction
12.1.1. Y-o-Y Growth Projections, By Country
12.1.2. Market Share & Basis Point (BPS) Analysis, By Country
12.2. Key Regulations
12.3. Key Trends
12.4. APAC Market Forecast
12.4.1. Market Value (US$ Mn) Forecast, By Country
12.4.1.1. Japan Absolute $ Opportunity
12.4.1.2. China Absolute $ Opportunity
12.4.1.3. Australia & New Zealand Absolute $ Opportunity
12.4.1.4. Rest of APAC Absolute $ Opportunity
12.4.2. Market Value (US$ Mn) Forecast, By Drug Class
12.4.3. Market Value (US$ Mn) Forecast, By Distribution Channel
12.5. Market Attractiveness Analysis
12.5.1. By Country
12.5.2. By Drug Class
12.5.3. By Distribution Channel

13. MEA Hepatitis C Treatment Market Analysis
13.1. Introduction
13.1.1. Y-o-Y Growth Projections, By Country
13.1.2. Market Share & Basis Point (BPS) Analysis, By Country
13.2. Key Regulations
13.3. Key Trends
13.4. MEA Market Forecast
13.4.1. Market Value (US$ Mn) Forecast, By Country
13.4.1.1. GCC Countries Absolute $ Opportunity
13.4.1.2. South Africa Absolute $ Opportunity
13.4.1.3. Rest of MEA Absolute $ Opportunity
13.4.2. Market Value (US$ Mn) Forecast, By Drug Class
13.4.3. Market Value (US$ Mn) Forecast, By Distribution Channel
13.5. Market Attractiveness Analysis
13.5.1. By Country
13.5.2. By Drug Class
13.5.3. By Distribution Channel
13.5.4. By Disease Indication

14. Competition Landscape
14.1. Competition Dashboard
14.2. Company Profiles Inclusions
14.2.1. Revenue
14.2.2. Products/Brand Offerings
14.2.3. Key developments
14.2.4. SWOT Analysis
14.3. Company Profiles
14.3.1. Gilead Sciences, Inc.
14.3.2. AbbVie Inc.
14.3.3. Kadmon Holdings, Inc.
14.3.4. F. Hoffmann-La Roche Ltd
14.3.5. GlaxoSmithKline plc.
14.3.6. Bristol-Myers Squibb Company
14.3.7. Merck & Co., Inc.
14.3.8. Johnson & Johnson

List of Table

Table 1: Global Hepatitis C Treatment Market Size and Forecast by Drug Class (US$ Mn) (20162024)
Table 2: Global Hepatitis C Treatment Market Size and Forecast by Distribution Channel (US$ Mn) (20162024)
Table 3: Global Hepatitis C Treatment Market Size and Forecast by Region (US$ Mn) (20162024)
Table 4: North America Hepatitis C Treatment Market Size and Forecast by Country (US$ Mn) (20162024)
Table 5: North America Hepatitis C Treatment Market Size and Forecast by Drug Class (US$ Mn) (20162024)
Table 6: North America Hepatitis C Treatment Market Size and Forecast by Distribution Channel (US$ Mn) (20162024)
Table 7: Latin America Hepatitis C Treatment Market Size and Forecast by Country (US$ Mn) (20162024)
Table 8: Latin America Hepatitis C Treatment Market Size and Forecast by Drug Class (US$ Mn) (20162024)
Table 9: Latin America Hepatitis C Treatment Market Size and Forecast by Distribution Channel (US$ Mn) (20162024)
Table 10: Europe Hepatitis C Treatment Market Size and Forecast by Country (US$ Mn) (20162024)
Table 11: Europe Hepatitis C Treatment Market Size and Forecast by Drug Class (US$ Mn) (20162024)
Table 12: Europe Hepatitis C Treatment Market Size and Forecast by Distribution Channel (US$ Mn) (20162024)
Table 13: APAC Hepatitis C Treatment Market Size and Forecast by Country (US$ Mn) (20162024)
Table 14: APAC Hepatitis C Treatment Market Size and Forecast by Drug Class (US$ Mn) (20162024)
Table 15: APAC Hepatitis C Treatment Market Size and Forecast by Distribution Channel (US$ Mn) (20162024)
Table 16: MEA Hepatitis C Treatment Market Size and Forecast by Country (US$ Mn) (20162024)
Table 17: MEA Hepatitis C Treatment Market Size and Forecast by Drug Class (US$ Mn) (20162024)
Table 18: MEA Hepatitis C Treatment Market Size and Forecast by Distribution Channel (US$ Mn) (20162024)

List of Chart

Figure 1: Global Hepatitis C Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 20162024
Figure 2: Global Hepatitis C Treatment Market Absolute $ Opportunity, 20162024
Figure 3: Global Hepatitis C Treatment Market Share and BPS Analysis (%) By Drug Class, 2016 & 2024
Figure 4: Global Hepatitis C Treatment Market Y-o-Y growth (%) By Drug Class, 20162024
Figure 5: Global Hepatitis C Treatment Market Value (US$ Mn) Forecast (20162024) By HCV Protease Inhibitors
Figure 6: Global Hepatitis C Treatment Market Absolute $ Opportunity by HCV Protease Inhibitors, 20162024
Figure 7: Global Hepatitis C Treatment Market Value (US$ Mn) Forecast (20162024) By HCV Polymerase Inhibitors
Figure 8: Global Hepatitis C Treatment Market Absolute $ Opportunity by HCV Polymerase Inhibitors, 20162024
Figure 9: Global Hepatitis C Treatment Market Value (US$ Mn) Forecast (20162024) By HCV NS5A Inhibitors
Figure 10: Global Hepatitis C Treatment Market Absolute $ Opportunity by HCV NS5A Inhibitors, 20162024
Figure 11: Global Hepatitis C Treatment Market Value (US$ Mn) Forecast (20162024) By Combination Therapy
Figure 12: Global Hepatitis C Treatment Market Absolute $ Opportunity by Combination Therapy, 20162024
Figure 13: Global Hepatitis C Treatment Market Value (US$ Mn) Forecast (20162024) By Ledipasvir & Sofosbuvir Sub-segment
Figure 14: Global Hepatitis C Treatment Market Value (US$ Mn) Forecast (20162024) By Ombitasvir, Paritaprevir, Ritonavir & Dasabuvir Sub-segment
Figure 15: Global Hepatitis C Treatment Market Value (US$ Mn) Forecast (20162024) By Elbasvir & Grazoprevir Sub-segment
Figure 16: Global Hepatitis C Treatment Market Value (US$ Mn) Forecast (20162024) By Others Sub-segment
Figure 17: Global Hepatitis C Treatment Market Value (US$ Mn) Forecast (20162024) By Interferon and Antiviral
Figure 18: Global Hepatitis C Treatment Market Absolute $ Opportunity by Interferon and Antiviral, 20162024
Figure 19: Global Hepatitis C Treatment Market Value (US$ Mn) Forecast (20162024) By Peginterferon alfa-2a Sub-segment
Figure 20: Global Hepatitis C Treatment Market Value (US$ Mn) Forecast (20162024) By Peginterferon alfa-2b Sub-segment
Figure 21: Global Hepatitis C Treatment Market Value (US$ Mn) Forecast (20162024) By Ribavirin Sub-segment
Figure 22: Global Hepatitis C Treatment Market Value (US$ Mn) Forecast (20162024) By Others Sub-segment
Figure 23: Global Hepatitis C Treatment Market Attractiveness Analysis by Drug Class, 20162024
Figure 24: Global Hepatitis C Treatment Market Share and BPS Analysis (%) By Distribution Channel, 2016 & 2024
Figure 25: Global Hepatitis C Treatment Market Y-o-Y growth (%) By Distribution Channel, 20162024
Figure 26: Global Hepatitis C Treatment Market Value (US$ Mn) Forecast (20162024) By Hospital Pharmacies Segment
Figure 27: Global Hepatitis C Treatment Market Absolute $ Opportunity by Hospital Pharmacies Segment, 20162024
Figure 28: Global Hepatitis C Treatment Market Value (US$ Mn) Forecast (20162024) By Retail Pharmacies Segment
Figure 29: Global Hepatitis C Treatment Market Absolute $ Opportunity by Retail Pharmacies Segment, 20162024
Figure 30: Global Hepatitis C Treatment Market Value (US$ Mn) Forecast (20162024) By Online Pharmacies Segment
Figure 31: Global Hepatitis C Treatment Market Absolute $ Opportunity by Online Pharmacies, 20162024
Figure 32: Global Hepatitis C Treatment Market Attractiveness Analysis by Distribution Channel, 20162024
Figure 33: North America Hepatitis C Treatment Market Value (US$ Mn) Forecast (20162024)
Figure 34: Latin America Hepatitis C Treatment Market Value (US$ Mn) Forecast (20162024)
Figure 35: Europe Hepatitis C Treatment Market Value (US$ Mn) Forecast (20162024)
Figure 36: APAC Hepatitis C Treatment Market Value (US$ Mn) Forecast (20162024)
Figure 37: MEA Hepatitis C Treatment Market Value (US$ Mn) Forecast (20162024)
Figure 38: Global Hepatitis C Treatment Market Attractiveness Analysis by Region, 20162024
Figure 39: North America Hepatitis C Treatment Market Share and BPS Analysis (%) By Country, 2016 & 2024
Figure 40: North America Hepatitis C Treatment Market Y-o-Y growth (%) By Country, 20162024
Figure 41: The U.S Hepatitis C Treatment Market Value (US$ Mn) Forecast (20162024)
Figure 42: The U.S Hepatitis C Treatment Market Absolute $ Opportunity, 20162024
Figure 43: Canada Hepatitis C Treatment Market Value (US$ Mn) Forecast (20162024)
Figure 44: Canada Hepatitis C Treatment Market Absolute $ Opportunity, 20162024
Figure 45: North America Hepatitis C Treatment Market Attractiveness Analysis by Country, 20162024
Figure 46: North America Hepatitis C Treatment Market Attractiveness Analysis by Drug Class, 20162024
Figure 47: North America Hepatitis C Treatment Market Attractiveness Analysis by Distribution Channel, 20162024
Figure 48: Latin America Hepatitis C Treatment Market Share and BPS Analysis (%) By Country, 2016 & 2024
Figure 49: Latin America Hepatitis C Treatment Market Y-o-Y growth (%) By Country, 20162024
Figure 50: Brazil Hepatitis C Treatment Market Value (US$ Mn) Forecast (20162024)
Figure 51: Brazil Hepatitis C Treatment Market Absolute $ Opportunity, 20162024
Figure 52: Mexico Hepatitis C Treatment Market Value (US$ Mn) Forecast (20162024)
Figure 53: Mexico Hepatitis C Treatment Market Absolute $ Opportunity, 20162024
Figure 54: Rest of Latin America Hepatitis C Treatment Market Value (US$ Mn) Forecast (20162024)
Figure 55: Rest of Latin America Hepatitis C Treatment Market Absolute $ Opportunity, 20162024
Figure 56: Latin America Hepatitis C Treatment Market Attractiveness Analysis by Country, 20162024
Figure 57: Latin America Hepatitis C Treatment Market Attractiveness Analysis by Drug Class, 20162024
Figure 58: Latin America Hepatitis C Treatment Market Attractiveness Analysis by Distribution Channel, 20162024
Figure 59: Europe Hepatitis C Treatment Market Share and BPS Analysis (%) By Country, 2016 & 2024
Figure 60: Europe Hepatitis C Treatment Market Y-o-Y growth (%) By Country, 20162024
Figure 61: U.K. Hepatitis C Treatment Market Value (US$ Mn) Forecast (20162024)
Figure 62: U.K. Hepatitis C Treatment Market Absolute $ Opportunity, 20162024
Figure 63: France Hepatitis C Treatment Market Value (US$ Mn) Forecast (20162024)
Figure 64: France Hepatitis C Treatment Market Absolute $ Opportunity, 20162024
Figure 65: Germany Hepatitis C Treatment Market Value (US$ Mn) Forecast (20162024)
Figure 66: Germany Hepatitis C Treatment Market Absolute $ Opportunity, 20162024
Figure 67: Rest of Europe Hepatitis C Treatment Market Value (US$ Mn) Forecast (20162024)
Figure 68: Rest of Europe Hepatitis C Treatment Market Absolute $ Opportunity, 20162024
Figure 69: Europe Hepatitis C Treatment Market Attractiveness Analysis by Country, 20162024
Figure 70: Europe Hepatitis C Treatment Market Attractiveness Analysis by Drug Class, 20162024
Figure 71: Europe Hepatitis C Treatment Market Attractiveness Analysis by Distribution Channel, 20162024
Figure 72: APAC Hepatitis C Treatment Market Share and BPS Analysis (%) By Country, 2016 & 2024
Figure 73: APAC Hepatitis C Treatment Market Y-o-Y growth (%) By Country, 20162024
Figure 74: Japan Hepatitis C Treatment Market Value (US$ Mn) Forecast (20162024)
Figure 75: Japan Hepatitis C Treatment Market Absolute $ Opportunity, 20162024
Figure 76: China Hepatitis C Treatment Market Value (US$ Mn) Forecast (20162024)
Figure 77: China Hepatitis C Treatment Market Absolute $ Opportunity, 20162024
Figure 78: Australia & New Zealand Hepatitis C Treatment Market Value (US$ Mn) Forecast (20162024)
Figure 79: Australia & New Zealand Hepatitis C Treatment Market Absolute $ Opportunity, 20162024
Figure 80: Rest of APAC Hepatitis C Treatment Market Value (US$ Mn) Forecast (20162024)
Figure 81: Rest of APAC Hepatitis C Treatment Market Absolute $ Opportunity, 20162024
Figure 82: APAC Hepatitis C Treatment Market Attractiveness Analysis by Country, 20162024
Figure 83: APAC Hepatitis C Treatment Market Attractiveness Analysis by Drug Class, 20162024
Figure 84: APAC Hepatitis C Treatment Market Attractiveness Analysis by Distribution Channel, 20162024
Figure 85: MEA Hepatitis C Treatment Market Share and BPS Analysis (%) By Country, 2016 & 2024
Figure 86: MEA Hepatitis C Treatment Market Y-o-Y growth (%) By Country, 20162024
Figure 87: GCC Countries Hepatitis C Treatment Market Value (US$ Mn) Forecast (20162024)
Figure 88: GCC Countries Hepatitis C Treatment Market Absolute $ Opportunity, 20162024
Figure 89: South Africa Hepatitis C Treatment Market Value (US$ Mn) Forecast (20162024)
Figure 90: South Africa Hepatitis C Treatment Market Absolute $ Opportunity, 20162024
Figure 91: Rest of MEA Hepatitis C Treatment Market Value (US$ Mn) Forecast (20162024)
Figure 92: Rest of MEA Hepatitis C Treatment Market Absolute $ Opportunity, 20162024
Figure 93: MEA Hepatitis C Treatment Market Attractiveness Analysis by Country, 20162024
Figure 94: MEA Hepatitis C Treatment Market Attractiveness Analysis by Drug Class, 20162024
Figure 95: MEA Hepatitis C Treatment Market Attractiveness Analysis by Distribution Channel, 20162024

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *